Your browser doesn't support javascript.
loading
Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies.
Fong, Raymond; Cavet, Megan E; DeCory, Heleen H; Vittitow, Jason L.
Affiliation
  • Fong R; Manhattan Eye, Ear and Throat Hospital and Lenox Hill Hospital, New York, NY, USA.
  • Cavet ME; Medical Affairs, Bausch + Lomb, Rochester, NY, USA.
  • DeCory HH; Medical Affairs, Bausch + Lomb, Rochester, NY, USA.
  • Vittitow JL; Clinical Affairs, Bausch + Lomb, Bridgewater, NJ, USA.
Clin Ophthalmol ; 13: 1427-1438, 2019.
Article in En | MEDLINE | ID: mdl-31447544
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Clin Ophthalmol Year: 2019 Document type: Article Affiliation country: United States Country of publication: New Zealand
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Clin Ophthalmol Year: 2019 Document type: Article Affiliation country: United States Country of publication: New Zealand